Home Covid News and Updates UK approves Bharat Biotech’s Covaxin as valid for travel

UK approves Bharat Biotech’s Covaxin as valid for travel

by Vaishali Sharma

Travelers who have been vaccinated with Bharat Biotech’s Covaxin will now be permitted to visit any region of the United Kingdom, as the vaccine was added to the country’s authorised list today, November 22. This implies that persons who have been immunised with Covaxin, one of the two primary Covid-19 vaccines used in India, will not need to self-isolate upon arrival in England.

The UK added India’s Covishield, the Oxford-AstraZeneca Covid-19 vaccine made in India, to its authorised list in October.

Earlier this month, British High Commissioner Alex Ellis had tweeted that the UK would recognise Covaxin as a valid Covid-19 vaccine for travel from November 22. Ellis wrote, “More good news for Indian travellers to Great Britain. From 22 November travellers fully vaccinated with a Covid-19 vaccine recognised by the WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield”.

The UK approved the Made in India vaccine for smoother travel after the UN body, the World Health Organization (WHO) issued an emergency-use listing for Covaxin on November 3. Apart from Covaxin, the UK government has also added China’s Sinovac and Sinopharm to its approved list of coronavirus vaccines.

You may also like